ArticleJournal of pharmaceutical policy and practice2026

Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in Japan.

Hiroaki Mamiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.